1,057 filings
Page 8 of 53
4
George Elston
30 May 23
EyePoint Pharmaceuticals / George Elston ownership change
5:13pm
144/A
EYPT
EyePoint Pharmaceuticals Inc
26 May 23
Notice of proposed sale of securities (amended)
10:34am
144/A
EYPT
EyePoint Pharmaceuticals Inc
26 May 23
Notice of proposed sale of securities (amended)
9:57am
144
Therapeutics OcuMension
26 May 23
Notice of proposed sale of securities
7:00am
8-K/A
EYPT
EyePoint Pharmaceuticals Inc
23 May 23
Financial Statements and Exhibits
5:24pm
8-K
EYPT
EyePoint Pharmaceuticals Inc
18 May 23
EyePoint Pharmaceuticals Announces Sale of YUTIQ® to Alimera Sciences, Inc. for $82.5 Million Cash Plus Royalties
7:06am
4
Nancy Lurker
15 May 23
EyePoint Pharmaceuticals / Nancy Lurker ownership change
6:15pm
10-Q
2023 Q1
EYPT
EyePoint Pharmaceuticals Inc
Quarterly report
4 May 23
2:41pm
8-K
EYPT
EyePoint Pharmaceuticals Inc
3 May 23
EyePoint Pharmaceuticals Reports First Quarter 2023 Financial Results and Highlights Recent Corporate Developments
7:05am
SC 13G/A
EYPT
EyePoint Pharmaceuticals Inc
1 May 23
EyePoint Pharmaceuticals / Cormorant Global Healthcare Master Fund ownership change
4:23pm
DEFA14A
EYPT
EyePoint Pharmaceuticals Inc
28 Apr 23
Additional proxy soliciting materials
4:02pm
DEF 14A
EYPT
EyePoint Pharmaceuticals Inc
Definitive proxy
28 Apr 23
4:01pm
8-K
EYPT
EyePoint Pharmaceuticals Inc
27 Mar 23
EyePoint Pharmaceuticals Completes Enrollment in Oversubscribed Phase 2 DAVIO 2 Clinical Trial of EYP-1901 for Maintenance Treatment of Wet AMD
7:05am
8-K
EYPT
EyePoint Pharmaceuticals Inc
10 Mar 23
Other Events
5:31pm
10-K
2022 FY
EYPT
EyePoint Pharmaceuticals Inc
Annual report
10 Mar 23
12:33pm
8-K
EYPT
EyePoint Pharmaceuticals Inc
2 Mar 23
EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Financial Results and Highlights Recent Corporate Developments
7:08am
SC 13G/A
EYPT
EyePoint Pharmaceuticals Inc
14 Feb 23
EyePoint Pharmaceuticals / RA CAPITAL MANAGEMENT ownership change
12:00am
4
David R Guyer
13 Feb 23
EyePoint Pharmaceuticals / DAVID R GUYER ownership change
5:08pm
4
EYPT
EyePoint Pharmaceuticals Inc
13 Feb 23
EyePoint Pharmaceuticals / Dario A. Paggiarino ownership change
5:07pm
4
Wendy F Dicicco
13 Feb 23
EyePoint Pharmaceuticals / WENDY F DICICCO ownership change
5:06pm